IP Library Assignment 046515/0222
Patent Assignment
Reel/Frame 046515/0222

Intellectual Property Security Agreement

Recorded: 2018-07-10 Pages: 20
Assignor
MESOBLAST INTERNATIONAL SARL
Executed: 2018-07-09
Assignee
NQP SPV II, L.P., AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
4208 SIX FORKS ROAD, SUITE 920, RALEIGH, NORTH CAROLINA, 27609
Covered Properties (15)
Mesenchymal Stem Cells for Prevention and Treatment of Immune Responses in Transplantation
Patent: 6,328,960 →
Application: 09/267,536 →
Mesenchymal Stem Cells for Prevention and Treatment of Immune Responses in Transplantation
Patent: 6,368,636 →
Application: 09/427,333 →
A Method of Preparing Suppressor T Cells with Allogeneic Mesenchymal Stem Cells
Patent: 6,281,012 →
Application: 09/563,768 →
Mesenchymal Stem Cells for Prevention and Treatment of Immune Responses in Transplantation
Patent: 6,875,430 →
Application: 10/067,121 →
Publication: US 2002/0085996
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Patent: 8,637,004 →
Application: 12/541,282 →
Publication: US 2010/0068191
Mesenchymal Stem Cells Expressing TNF-alpha Receptors
Patent: 8,486,695 →
Application: 13/402,498 →
Publication: US 2012/0214178
Mesenchymal Stem Cells and Uses Therefor
Patent: 9,943,547 →
Application: 14/087,830 →
Publication: US 2014/0154276
Enhanced Msc Preparations
Patent: 9,828,586 →
Application: 14/138,265 →
Publication: US 2014/0112893
Mesenchymal Stem Cells and Uses Therefor
Application: 14/138,577 →
Publication: US 2014/0161776
Mesenchymal Stem Cells and Uses Therefor
Patent: 9,694,035 →
Application: 14/334,128 →
Publication: US 2015/0017132
Enhanced Msc Preparations
Patent: 9,963,678 →
Application: 14/662,344 →
Publication: US 2015/0247122
Mesenchymal Stem Cells and Uses Therefor
Application: 14/739,924 →
Publication: US 2015/0272997
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Application: 15/602,848 →
Publication: US 2018/0008642
Mesenchymal Stem Cells Expressing Tnf-Alpha Receptors
Application: 15/693,754 →
Publication: US 2018/0087032
Enhanced Msc Preparation
Application: 15/945,148 →
Publication: US 2018/0291347
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 4, 2012
From: DANILKOVITCH, ALLA; CARTER, DIANE; TYRELL, ALICIA; BUBNIC, SIMON
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 028160/0189 →
Corrective Assignment to Correct the Assignor Doc Dates Previously Recorded on Reel 028160 Frame 0189. Assignor(S) Hereby Confirms the Dates of Execution of Assignment Document. May 25, 2012
From: DANILKOVITCH, ALLA; CARTER, DIANE; TYRELL, ALICIA; BUBNIC, SIMON
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 028275/0301 →
Assignment of Assignor's Interest Nov 1, 2013
From: OSIRIS THERAPEUTICS, INC.
To: MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 031533/0828 →
Assignment of Assignor's Interest Dec 19, 2013
From: AGGARWAL, SUDEEPTA; PITTENGER, MARK F.; VARNEY, TIMOTHY R.
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 031821/0141 →
Assignment of Assignor's Interest Dec 19, 2013
From: OSIRIS THERAPEUTICS, INC.
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 031821/0437 →
Assignment of Assignor's Interest Oct 22, 2014
From: AGGARWAL, SUDEEPTA; PITTENGER, MARK F.; VARNEY, TIMOTHY R.
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 034001/0950 →
Assignment of Assignor's Interest Oct 22, 2014
From: OSIRIS THERAPEUTICS, INC.
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 034004/0594 →
Assignment of Assignor's Interest Oct 22, 2014
From: TOM, SAMSON, DR.; TON, CHRISTOPHER, DR.; DANILKOVITCH, ALLA, DR.
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 034004/0353 →
Assignment of Assignor's Interest Oct 22, 2014
From: OSIRIS THERAPEUTICS, INC.
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 034002/0030 →
Assignment of Assignor's Interest Mar 3, 2017
From: OSIRIS THERAPEUTICS, INC.
To: MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 041453/0169 →
Assignment of Assignor's Interest Mar 3, 2017
From: AGGARWAL, SUDEEPTA; PITTENGER, MARK F.; VARNEY, TIMOTHY
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 041453/0135 →
Assignment of Assignor's Interest Jan 18, 2018
From: TON, CHRISTOPHER, DR.; DANILKOVITCH, ALLA, DR.; TOM, SAMSON, DR.
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 044658/0068 →
Assignment of Assignor's Interest Jan 18, 2018
From: OSIRIS THERAPEUTICS, INC.
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 044658/0721 →
Assignment of Assignor's Interest Feb 28, 2018
From: OSIRIS THERAPEUTICS, INC.
To: MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 045066/0947 →
Assignment of Assignor's Interest Feb 28, 2018
From: DANILKOVITCH, ALLA; CARTER, DIANE; TYRELL, ALICIA; BUBNIC, SIMON
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 045066/0603 →
Assignment of Assignor's Interest Feb 28, 2018
From: DANILKOVITCH, ALLA; NEWMAN, ROBERT E., JR.; TOM, SAMSON; TON, CHRISTOPHER
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 045066/0225 →
Intellectual Property Security Agreement Mar 28, 2018
From: MESOBLAST INTERNATIONAL SARL
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0917 →
Assignment of Assignor's Interest Mar 26, 2019
From: TOM, SAMSON; TON, CHRISTOPHER; DANILKOVITCH, ALLA
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 048695/0151 →
Assignment of Assignor's Interest Mar 26, 2019
From: OSIRIS THERAPEUTICS, INC.
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 048695/0168 →
Security Interest Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Release of Intellectual Property Security Agreement at Reel/Frame No. 45759/0917 Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 072297/0753 →
Release of Security Interest in Intellectual Property Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →